References
- Adams, L. M., Balderson, B. H., Brown, K., Bush, S. E., & Packett, B. J., 2nd. (2018). Who starts the conversation and who receives preexposure prophylaxis (PrEP)? A brief online survey of medical providers’ PrEP practices. Health Education & Behavior, 45(5), 723–729. https://doi.org/10.1177/1090198117752789
- Bacon, O., Gonzalez, R., Andrew, E., Potter, M. B., Iniguez, J. R., Cohen, S. E., Liu, A. Y., & Fuchs, J. D. (2017). Informing strategies to build PrEP capacity among San Francisco Bay area clinicians. Journal of Acquired Immune Deficiency Syndromes, 74(2), 175–179. https://doi.org/10.1097/qai.0000000000001182
- Bleasdale, J., Wilson, K., Aidoo-Frimpong, G., & Przybyla, S. (2020). Prescribing HIV pre-exposure prophylaxis: A qualitative analysis of health care provider training needs. Journal of HIV/AIDS & Social Services, 19(1), 1–17. https://doi:10.1080/15381501.2020.1712291
- Blumenthal, J., Jain, S., Krakower, D., Sun, X., Young, J., Mayer, K., & Haubrich, R. (2015). Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS and Behavior, 19(5), 802–810. https://doi.org/10.1007/s10461-015-0996-z
- Braun, V., & Clarke, V. (2012). APA handbook of research methods in psychology, Vol 2: Research designs: Quantitative, qualitative, neuropsychological, and biological. American Psychological Association.
- Bronfenbrenner, U. (1979). The ecology of human development. Harvard University Press.
- Caceres, C. F., Koechlin, F., Goicochea, P., Sow, P. S., O’Reilly, K. R., Mayer, K. H., & Godfrey-Faussett, P. (2015). The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention. Journal of the International AIDS Society, 18(4 Suppl 3), 19949. https://doi.org/10.7448/ias.18.4.19949
- Calabrese, S. K., Krakower, D. S., & Mayer, K. H. (2017). Integrating HIV preexposure prophylaxis (PrEP) into routine preventive health care to avoid exacerbating disparities. American Journal of Public Health, 107(12), 1883–1889. https://doi.org/10.2105/ajph.2017.304061
- Calabrese, S. K., Magnus, M., Mayer, K. H., Krakower, D. S., Eldahan, A. I., Gaston Hawkins, L. A., Hansen, N. B., Kershaw, T. S., Underhill, K., Betancourt, J. R., & Dovidio, J. F. (2016). Putting PrEP into practice: Lessons learned from early-adopting U.S. providers’ firsthand experiences providing HIV pre-exposure prophylaxis and associated care. Plos One, 11(6), e0157324–e0157324. https://doi.org/10.1371/journal.pone.0157324
- Cegala, D. J. (2011). An exploration of factors promoting patient participation in primary care medical interviews. Health Communication, 26(5), 427–436. https://doi.org/10.1080/10410236.2011.552482
- Centers for Disease Control and Prevention. (2018a). HIV surveillance supplemental report: Estimated HIV incidence and prevalence in the United States 2010–2015 (Report No. 1).
- Centers for Disease Control and Prevention. (2018b). US public health service: Preexposure prophylaxis for the prevention of HIV infection in the United State – 2017 Update: Clinical practice guideline.
- Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., Chuachoowong, R., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Hendrix, C. W., & Vanichseni, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 381(9883), 2083–2090. https://doi.org/10.1016/s0140-6736(13)61127-7
- Collier, K. L., Colarossi, L. G., & Sanders, K. (2017). Raising awareness of pre-exposure prophylaxis (PrEP) among women in New York City: Community and provider perspectives. Journal of Health Communication, 22(3), 183–189. https://doi.org/10.1080/10810730.2016.1261969
- Duggan, A. (2006). Understanding interpersonal communication processes across health contexts: Advances in the last decade and challenges for the next decade. Journal of Health Communication, 11(1), 93–108. https://doi.org/10.1080/10810730500461125
- Fauci, A. S., Redfield, R. R., Sigounas, G., Weahkee, M. D., & Giroir, B. P. (2019). Ending the HIV epidemic: A plan for the United States. Journal of the American Medical Association, 321(9): 844–845. https://doi.org/10.1001/jama.2019.1343
- Garden, R. L., & Seiler, W. J. (2017). Serious illness conversations with doctors: Patients using information obtained from sources other than their doctors. Health Communication, 32(1), 22–31. https://doi.org/10.1080/10410236.2015.1092061
- Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapia, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., Montoya-Herrera, O., Fernandez, T., Veloso, V. G., Buchbinder, S. P., Chariyalertsak, S., Schechter, M., Bekker, L. G., Mayer, K. H., Kallas, E. G., & Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England Journal of Medicine, 363(27), 2587–2599. https://doi.org/10.1056/NEJMoa1011205
- Ha, J. F., Anat, D. S., & Longnecker, N. (2010). Doctor-patient communication: A review. The Ochsner Journal, 10(1), 38–43. http://www.ochsnerjournal.org/content/10/1/38
- Head, K. J., & Bute, J. J. (2018). The influence of everyday interpersonal communication on the medical encounter: An extension of Street’s ecological model. Health Communication, 33(6), 786–792. https://doi.org/10.1080/10410236.2017.1306474
- Hoffman, S., Guidry, J. A., Collier, K. L., Mantell, J. E., Boccher-Lattimore, D., Kaighobadi, F., & Sandfort, T. G. (2016). A clinical home for preexposure prophylaxis: Diverse health care providers’ perspectives on the “purview paradox”. Journal of the International Association of Providers of AIDS Care, 15(1), 59–65. https://doi.org/10.1177/2325957415600798
- Kanny, D., Jeffries, W. L., Chapin-Bardales, J., Denning, P., Cha, S., Finlayson, T., & Wejnert, C. (2019). Racial/Ethnic disparities in HIV preexposure prophylaxis among men who have sex with men - 23 urban areas, 2017. Morbidity and Mortality Weekly Report, 68(37), 801–806. https://doi.org/10.15585/mmwr.mm6837a2
- Karris, M. Y., Beekmann, S. E., Mehta, S. R., Anderson, C. M., & Polgreen, P. M. (2014). Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clinical Infectious Diseases, 58(5), 704–712. https://doi.org/10.1093/cid/cit796
- Krakower, D. S., Gruber, S., Hsu, K., Menchaca, J. T., Maro, J. C., Kruskal, B. A., Wilson, I. B., Mayer, K. H., & Klompas, M. (2019). Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: A modelling study. Lancet HIV, 6(10), e696–e704. https://doi.org/10.1016/s2352-3018(19)30139-0
- Krakower, D. S., Maloney, K. M., Grasso, C., Melbourne, K., & Mayer, K. H. (2016). Primary care clinicians’ experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: Lessons from early adopters. Journal of the International AIDS Society, 19(1), 21165. https://doi.org/10.7448/ias.19.1.21165
- Krakower, D. S., Oldenburg, C. E., Mitty, J. A., Wilson, I. B., Kurth, A. E., Maloney, K. M., Gallagher, D., & Mayer, K. H. (2015). Knowledge, beliefs and practices regarding antiretroviral medications for HIV prevention: Results from a survey of healthcare providers in New England. PLOS One, 10(7), e0132398. https://doi.org/10.1371/journal.pone.0132398
- Mayer, K. H., Chan, P. A., Patel, R. R., Flash, C. A., & Krakower, D. S. (2018). Evolving models and ongoing challenges for HIV preexposure prophylaxis implementation in the United States. Journal of Acquired Immune Deficiency Syndromes, 77(2), 119–127. https://doi.org/10.1097/qai.0000000000001579
- McLeroy, K. R., Bibeau, D., Steckler, A., & Glanz, K. (1988). An ecological perspective on health promotion programs. Health Education Quarterly, 15(4), 351–377. https://doi.org/10.1177/109019818801500401
- National Center for HIV/AIDS, V. H., STD, and TB Prevention. (2018). HIV prevention pill not reaching most Americans who could benefit – Especially people of color [Press release].
- National Center for HIV/AIDS, V. H., STD, and TB Prevention. (2019). CDC’S work preventing HIV, viral hepatitis. STDs, and TB in the United States.
- New York State Clinical Education Initiative. (2018). About: Clinical education initiative. https://ceitraining.org/
- New York State Department of Health AIDS Institute. (2019). NYS progress to end the epidemic by the end of 2020. https://www.health.ny.gov/diseases/aids/ending_the_epidemic/index.htm
- Nunn, A. S., Brinkley-Rubinstein, L., Oldenburg, C. E., Mayer, K. H., Mimiaga, M., Patel, R., & Chan, P. A. (2017). Defining the HIV pre-exposure prophylaxis care continuum. AIDS, 31(5), 731–734. https://doi.org/10.1097/qad.0000000000001385
- Padgett, D. (2012). Qualitative and mixed methods in public health (2nd ed.). SAGE.
- Parisi, D., Warren, B., Leung, S. J., Akkaya-Hocagil, T., Qin, Q., Hahn, I., & Stevens, L. (2018). A multicomponent approach to evaluating a pre-exposure prophylaxis (PrEP) implementation program in five agencies in New York. Journal of the Association of Nurses in AIDS Care, 29(1), 10–19. https://doi.org/10.1016/j.jana.2017.06.006
- Petroll, A. E., Walsh, J. L., Owczarzak, J. L., McAuliffe, T. L., Bogart, L. M., & Kelly, J. A. (2017). PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS and Behavior, 21(5), 1256–1267. https://doi.org/10.1007/s10461-016-1625-1
- Philbin, M. M., Parker, C. M., Parker, R. G., Wilson, P. A., Garcia, J., & Hirsch, J. S. (2016). The promise of pre-exposure prophylaxis for black men who have sex with men: An ecological approach to attitudes, beliefs, and barriers. AIDS Patient Care and STDS, 30(6), 282–290. https://doi.org/10.1089/apc.2016.0037
- Przybyla, S., LaValley, S., & St Vil, N. (2019). Health care provider perspectives on pre-exposure prophylaxis: A qualitative study. Journal of the Association of Nurses in AIDS Care, 30(6), 630–638. https://doi.org/10.1097/jnc.0000000000000073
- Rael, C. T., Martinez, M., Giguere, R., Bockting, W., MacCrate, C., Mellman, W., Valente, P., Greene, G. J., Sherman, S., Footer, K. H. A., D’Aquila, R. T., & Carballo-Diéguez, A. (2018). Barriers and facilitators to oral PrEP use among transgender women in New York City. AIDS and Behavior, 22(11), 3627–3636. https://doi.org/10.1007/s10461-018-2102-9
- Saberi, P., Berrean, B., Thomas, S., Gandhi, M., & Scott, H. (2018). A simple pre-exposure prophylaxis (PrEP) optimization intervention for health care providers prescribing PrEP: Pilot study. JMIR Formative Research, 2(1), e2. https://doi.org/10.2196/formative.8623
- Schwartz, J., & Grimm, J. (2019). Stigma communication surrounding PrEP: The experiences of a sample of men who have sex with men. Health Communication, 34(1), 84–90. https://doi.org/10.1080/10410236.2017.1384430
- Seidman, D., & Weber, S. (2016). Integrating preexposure prophylaxis for human immunodeficiency virus prevention into women’s health care in the United States. Obstetrics & Gynecology, 128(1), 37–43. https://doi.org/10.1097/aog.0000000000001455
- Sharma, M., Chris, A., Chan, A., Knox, D. C., Wilton, J., McEwen, O., Mishra, S., Grace, D., Rogers, T., Bayoumi, A. M., Maxwell, J., Shahin, R., Bogoch, I., Gilbert, M., & Tan, D. H. S. (2018). Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: A dissemination and implementation study protocol. BMC Health Services Research, 18(1), 513. https://doi.org/10.1186/s12913-018-3324-2
- Signorelli, D., & Joseph, R. J., 2nd. (1998). Epidemiology of HIV and AIDS. A retrospective look. Clinics in Podiatric Medicine and Surgery, 15(2), 179–187.
- Silapaswan, A., Krakower, D., & Mayer, K. H. (2016). Pre-exposure prophylaxis: A narrative review of provider behavior and interventions to increase PrEP implementation in primary care. Journal of General Internal Medicine, 32(2), 192–198. https://doi.org/10.1007/s11606-016-3899-4
- Smith, D. K., Chang, M. H., Duffus, W. A., Okoye, S., & Weissman, S. (2018). Missed opportunities to prescribe preexposure prophylaxis in South Carolina, 2013-2016. Clinical Infectious Diseases, 68(1), 37–42. https://doi.org/10.1093/cid/ciy441
- Smith, D. K., Van Handel, M., & Grey, J. (2018). Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Annals of Epidemiology, 28(12), 850–857.e859. https://doi.org/10.1016/j.annepidem.2018.05.003
- St.Vil, N. M., Przybyla, S., & LaValley, S. (2019). Barriers and facilitators to initiating PrEP conversations: Perspectives and experiences of health care providers. Journal of HIV/AIDS & Social Services, 18(2), 166–179. https://doi.org/10.1080/15381501.2019.1616027
- Street, R. (2003). Communication in medical encounters: An ecological perspective. In T. L. Thompson, A. Dorsey, R. Parrott, & K. Miller (Eds.), Handbook of Health Communication (pp. 63–89). Lawrence Erlbaum Associates.
- Sullivan, P. S., Giler, R. M., Mouhanna, F., Pembleton, E. S., Guest, J. L., Jones, J., Castel, A. D., Yeung, H., Kramer, M., McCallister, S., & Siegler, A. J. (2018). Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017. Annals of Epidemiology, 28(12), 833–840. https://doi.org/10.1016/j.annepidem.2018.06.009
- Tekeste, M., Hull, S., Dovidio, J. F., Safon, C. B., Blackstock, O., Taggart, T., Kershaw, T. S., Kaplan, C., Caldwell, A., Lane, S. B., & Calabrese, S. K. (2019). Differences in medical mistrust between black and white women: Implications for patient-provider communication about PrEP. AIDS and Behavior, 23(7), 1737–1748. https://doi.org/10.1007/s10461-018-2283-2
- Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., Mutanhaurwa, R., Chirwa, L., Kasonde, M., Abebe, D., Buliva, E., Gvetadze, R. J., Johnson, S., & Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. The New England Journal of Medicine, 367(5), 423–434. https://doi.org/10.1056/NEJMoa1110711
- United States Department of Health and Human Services. (2012). FDA approves first drug for reducing the risk of sexually acquired HIV infection [Press release].
- Walsh, J. L., & Petroll, A. E. (2017). Factors related to pre-exposure prophylaxis prescription by U.S. primary care physicians. American Journal of Preventive Medicine, 52(6), e165–e172. https://doi.org/10.1016/j.amepre.2017.01.025
- Wu, H., Mendoza, M. C., Huang, Y. A., Hayes, T., Smith, D. K., & Hoover, K. W. (2017). Uptake of HIV preexposure prophylaxis among commercially insured persons-United States, 2010-2014. Clinical Infectious Diseases, 64(2), 144–149. https://doi.org/10.1093/cid/ciw701